लोड हो रहा है...
Total knee replacement with and without emicizumab: a unique comparison of perioperative management
Prophylaxis with emicizumab was used in a patient with severe hemophilia with an inhibitor who underwent knee surgery. Use of emicizumab during surgery led to less recombinant factor VIIa and less bleeding, in addition to cost savings, for this patient.
में बचाया:
| में प्रकाशित: | Blood Adv |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
American Society of Hematology
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7065482/ https://ncbi.nlm.nih.gov/pubmed/32126140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001060 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|